ACTIVE

apotheek Maes

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

77,5 k €

-9.8% YoY

Gross margin

290 k €

-5.0% YoY

Equity

85,7 k €

+3.1% YoY

Workforce

2,6 ETP

-13.3% YoY

What does apotheek Maes do?

apotheek Maes is a Private limited company incorporated in 2005. Its main activity is: Dispensing chemist in specialised stores. It employs on average 2,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0874.956.826

Incorporation

30/06/2005

Legal form

Private limited company

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Average workforce

2,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores 52320Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	290 k €	-5.0%	305,4 k €	+18.1%	258,7 k €	-3.9%	269,1 k €	+2.7%	262,1 k €	+2.3%	256,2 k €	+10.8%	231,2 k €	-9.0%	254,2 k €	+2.8%	247,1 k €	-4.5%	258,7 k €	+27.5%	202,9 k €	+6.1%	191,1 k €	+52.8%	125,1 k €	+25.1%	100 k €	+12.0%	89,3 k €	+6.2%	84,1 k €	+34.5%	62,5 k €	+14.8%	54,5 k €	-23.5%	71,2 k €	-30.9%	103,1 k €
EBITDA	110,9 k €	-5.4%	117,3 k €	+40.6%	83,4 k €	-6.9%	89,5 k €	-12.3%	102,1 k €	-3.6%	105,9 k €	+8.3%	97,8 k €	-29.6%	138,9 k €	+2.2%	136 k €	-17.8%	165,3 k €	+34.5%	123 k €	+3.7%	118,6 k €	+20.4%	98,5 k €	+4.0%	94,7 k €	+32.0%	71,8 k €	+15.1%	62,3 k €	+72.6%	36,1 k €	+125%	16,1 k €	-32.6%	23,8 k €	-36.2%	37,4 k €
Operating result	90,3 k €	-6.7%	96,7 k €	+58.7%	61 k €	+16.5%	52,3 k €	-14.5%	61,2 k €	+1.6%	60,2 k €	+17.3%	51,3 k €	-45.4%	94 k €	+2.2%	92 k €	-30.5%	132,4 k €	+79.1%	73,9 k €	+48.2%	49,8 k €	+58.5%	31,5 k €	-20.0%	39,3 k €	+22.3%	32,1 k €	+48.8%	21,6 k €	+768%	-3,2 k €	+86.2%	-23,4 k €	-49.8%	-15,6 k €	+57.8%	-37 k €
Net result	77,5 k €	-9.8%	86 k €	+71.9%	50 k €	+50.4%	33,3 k €	-27.8%	46,1 k €	+19.7%	38,5 k €	+59.2%	24,2 k €	-42.3%	41,9 k €	-3.1%	43,3 k €	-52.8%	91,6 k €	+142%	37,9 k €	+566%	5,7 k €	+821%	617,8 €	-62.0%	1,6 k €	-57.5%	3,8 k €	+158%	-6,6 k €	+81.2%	-35 k €	+32.7%	-52 k €	-315%	-12,5 k €	+76.2%	-52,7 k €
Balance sheet
Equity	85,7 k €	+3.1%	83,2 k €	+7.8%	77,2 k €	+0.0%	77,2 k €	+4.4%	73,9 k €	+9.0%	67,8 k €	+14.4%	59,3 k €	+18.4%	50,1 k €	+116%	23,2 k €	+551%	-5,1 k €	+94.7%	-96,8 k €	+28.1%	-134,7 k €	+4.1%	-140,3 k €	+0.4%	-141 k €	+1.1%	-142,6 k €	+2.6%	-146,4 k €	-4.7%	-139,8 k €	-33.4%	-104,8 k €	-98.5%	-52,8 k €	-31.1%	-40,3 k €
Total assets	831,5 k €	-0.1%	832,7 k €	-2.8%	856,3 k €	+8.1%	792,2 k €	+3.9%	762,8 k €	-6.0%	811,7 k €	-3.1%	837,3 k €	+0.0%	837,3 k €	-3.9%	871,7 k €	+20.7%	722,1 k €	+1.6%	710,6 k €	+39.6%	509,2 k €	-36.0%	795,2 k €	+19.9%	663,4 k €	+3.3%	642,1 k €	-4.0%	668,9 k €	+6.1%	630,4 k €	-12.7%	722,2 k €	-0.6%	726,2 k €	-4.3%	758,5 k €
Cash	143,5 k €	+4.9%	136,8 k €	+4.4%	131 k €	+41.1%	92,8 k €	-7.5%	100,3 k €	-22.6%	129,6 k €	+44.5%	89,7 k €	-19.8%	111,9 k €	-6.1%	119,2 k €	-11.6%	134,8 k €	+14.2%	118 k €	+2.6%	115,1 k €	+79.2%	64,2 k €	+96.5%	32,7 k €	+405%	6,5 k €	-50.0%	12,9 k €	-22.4%	16,7 k €	-83.3%	99,8 k €	+197%	33,6 k €	+246%	9,7 k €
Debts	745,8 k €	-0.5%	749,5 k €	-3.8%	779,1 k €	+9.0%	715,1 k €	+4.2%	686,6 k €	-7.7%	743,9 k €	-4.4%	778 k €	-1.2%	787,2 k €	-7.2%	848,5 k €	+16.7%	727,2 k €	-9.9%	807,3 k €	+25.4%	643,8 k €	-31.2%	935,6 k €	+16.8%	800,8 k €	+2.9%	778,6 k €	-3.9%	809,9 k €	+5.6%	767,3 k €	-7.2%	827 k €	+6.3%	778,2 k €	-2.3%	796,9 k €
Other
Workforce	2,6 ETP	-13.3%	3,0 ETP	+7.1%	2,8 ETP	-3.4%	2,9 ETP	+7.4%	2,7 ETP	0.0%	2,7 ETP	0.0%	2,7 ETP	+42.1%	1,9 ETP	-9.5%	2,1 ETP	+10.5%	1,9 ETP	+18.7%	1,6 ETP	+14.3%	1,4 ETP	+180%	0,5 ETP	+400%	0,1 ETP	-85.7%	0,7 ETP	+16.7%	0,6 ETP	+20.0%	0,5 ETP	-16.7%	0,6 ETP	-40.0%	1,0 ETP	+11.1%	0,9 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

MANAGEMENT JUMAPA

Director · 0848.093.269

Represented by Maes Julie

Active

Ended mandates

apotheek Maes

Manager · 0874.956.826

Represented by Julie Maes

Ended

apotheek Maes

Director · 0874.956.826

Represented by Julie Maes

Ended

apotheek Maes

Manager · 0874.956.826

Represented by Julie Maes

Ended

apotheek Maes

Director · 0874.956.826

Represented by Julie Maes

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/08/2026	30/09/2025	30/08/2024	01/09/2023	26/07/2022	31/08/2021
General meeting	27/08/2026	02/06/2025	03/06/2024	05/06/2023	06/06/2022	07/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	27/08/2026	28/08/2026	Dutch	PDF
Abridged model	31/12/2024	02/06/2025	30/09/2025	Dutch	PDF
Abridged model	31/12/2023	03/06/2024	30/08/2024	Dutch	PDF
Abridged model	31/12/2022	05/06/2023	01/09/2023	Dutch	PDF
Abridged model	31/12/2021	06/06/2022	26/07/2022	Dutch	PDF
Abridged model	31/12/2020	07/06/2021	31/08/2021	Dutch	PDF
Abridged model	31/12/2019	31/08/2020	28/09/2020	Dutch	PDF
Abridged model	31/12/2018	27/06/2019	05/08/2019	Dutch	PDF
Abridged model	31/12/2017	04/06/2018	29/06/2018	Dutch	PDF
Abridged model	31/12/2016	06/06/2017	20/06/2017	Dutch	PDF
Abridged model	31/12/2015	06/06/2016	01/07/2016	Dutch	PDF
Abridged model	31/12/2014	01/06/2015	15/06/2015	Dutch	PDF
Abridged model	31/12/2013	09/06/2014	07/07/2014	Dutch	PDF
Abridged model	31/12/2012	03/06/2013	14/06/2013	Dutch	PDF
Abridged model	31/12/2011	04/06/2012	27/06/2012	Dutch	PDF
Abridged model	31/12/2010	06/06/2011	28/06/2011	Dutch	PDF
Abridged model	31/12/2009	07/06/2010	30/06/2010	Dutch	PDF
Abridged model	31/12/2008	01/06/2009	01/07/2009	Dutch	PDF
Abridged model	31/12/2007	02/06/2008	14/07/2008	Dutch	PDF
Abridged model	31/12/2006	04/06/2007	02/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

MANAGEMENT JUMAPA

Director · 0848.093.269

Represented by Maes Julie

Active

Ended mandates

apotheek Maes

Manager · 0874.956.826

Represented by Julie Maes

Ended

apotheek Maes

Director · 0874.956.826

Represented by Julie Maes

Ended

apotheek Maes

Manager · 0874.956.826

Represented by Julie Maes

Ended

apotheek Maes

Director · 0874.956.826

Represented by Julie Maes

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates28/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/11/2012
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/09/2012
BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/03/2009
ONTSLAGEN - BENOEMINGEN
PDF
Other18/07/2005
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202577,5 k €↓
2024
Annual accounts 202486 k €↑
2023
Annual accounts 202350 k €↑
2022
Annual accounts 202233,3 k €↓
2021
Annual accounts 202146,1 k €↑
2020
Annual accounts 202038,5 k €↑
2019
Annual accounts 201924,2 k €↓
2018
Annual accounts 201841,9 k €↓
2017
Annual accounts 201743,3 k €↓
2016
Annual accounts 201691,6 k €↑
2015
Annual accounts 201537,9 k €↑
2014
Annual accounts 20145,7 k €↑
2013
Annual accounts 2013617,8 €↓
2012
Annual accounts 20121,6 k €↓
2011
Annual accounts 20113,8 k €↑
2010
Annual accounts 2010-6,6 k €↑
2009
Annual accounts 2009-35 k €↑
2008
Annual accounts 2008-52 k €↓
2007
Annual accounts 2007-12,5 k €↑
2006
Annual accounts 2006-52,7 k €
30/06/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

apotheek Maes

Overview

What does apotheek Maes do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline